International Myeloma Foundation (IMF) Honors 2025 Kyle and Durie Achievement Awardees, Dr. Sagar Lonial and Dr. Sonja Zweegman Read more about International Myeloma Foundation (IMF) Honors 2025 Kyle and Durie Achievement Awardees, Dr. Sagar Lonial and Dr. Sonja Zweegman Add new comment
From Clinical Research News: Many Approaches Collectively Aim at a Cure for Myeloma Read more about From Clinical Research News: Many Approaches Collectively Aim at a Cure for MyelomaAdd new comment
Important New Data and Results from Myeloma Research Trials Unveiled at ASCO 2025 Read more about Important New Data and Results from Myeloma Research Trials Unveiled at ASCO 2025Add new comment
CHMP of the European Medicines Agency Recommends Approval of Blenrep (belantamab mafodotin) for Relapsed/Refractory Multiple Myeloma Read more about CHMP of the European Medicines Agency Recommends Approval of Blenrep (belantamab mafodotin) for Relapsed/Refractory Multiple Myeloma Add new comment
FDA ODAC Votes in Support of DARZALEX FASPRO for High-Risk Smoldering Myeloma Read more about FDA ODAC Votes in Support of DARZALEX FASPRO for High-Risk Smoldering MyelomaAdd new comment
May 2025 – Myeloma News from the Journals Read more about May 2025 – Myeloma News from the JournalsAdd new comment
2025 Myeloma Action Month Celebrates #MyelomaMilestones Read more about 2025 Myeloma Action Month Celebrates #MyelomaMilestonesAdd new comment
The International Myeloma Foundation Mourns the Loss of Board Member and Longtime Philanthropist John O’Dwyer Read more about The International Myeloma Foundation Mourns the Loss of Board Member and Longtime Philanthropist John O’DwyerAdd new comment
European Commission Grants Conditional Marketing Approval of Lynozyfi (linvoseltamab) for Relapsed/Refractory Multiple Myeloma Read more about European Commission Grants Conditional Marketing Approval of Lynozyfi (linvoseltamab) for Relapsed/Refractory Multiple MyelomaAdd new comment
